Advanced colorectal cancer is a significant cause of cancer mortality in in
dustrialised countries. 5-fluorouracil hers remained the principal drug use
d in treating this disease, and although it has tangibly improved patient o
utcome, further gains can potentially be made. This review focuses on the c
urrent development of novel therapeutic agents which have potential in the
treatment of colorectal cancer.